PEOPLE - Ixion (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Louis Kessler has been appointed vice-president of corporate development at Ixion of Alachua, Florida. Mr Kessler was previously director of intellectual properties and technology transfer at Univax Biologics/Nabi, a biopharmaceutical company. Ixion develops diagnostic and prevention options for oxalate-based disorders, such as kidney stones, primary hyperoxaluria, Crohn's Disease and cystic fibrosis.